An electrophoretic mobility shift assay identifies a mechanistically unique inhibitor of protein sumoylation

Chemistry and Biology

Volumn 20, Issue 4, 2013, Pages 604-613

  Kim, Yeong Sang ^a   Nagy, Katelyn ^a,b   Keyser, Samantha ^a   Schneekloth, John S ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF DELAWARE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA TOPOISOMERASE; FLAVONOID; SUMO 1 PROTEIN; SUMO PROTEIN;

ALKYLATION; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; GEL MOBILITY SHIFT ASSAY; IN VITRO STUDY; MICROFLUIDICS; OXYGENATION; PHARMACOPHORE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN PROCESSING; SCREENING; STRUCTURE ACTIVITY RELATION; SUMOYLATION; UBIQUITINATION;

EID: 84876486754     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chembiol.2013.04.001     Document Type: Article

References (53)

1. A.Y. Alontaga, E. Bobkova, and Y. Chen Biochemical analysis of protein SUMOylation Curr. Protoc. Mol. Biol. Chapter 10 2012 Unit10 29
2. E.A. Andrews, J. Palecek, J. Sergeant, E. Taylor, A.R. Lehmann, and F.Z. Watts Nse2, a component of the Smc5-6 complex, is a SUMO ligase required for the response to DNA damage Mol. Cell. Biol. 25 2005 185 196
3. L. Bedford, J. Lowe, L.R. Dick, R.J. Mayer, and J.E. Brownell Ubiquitin-like protein conjugation and the ubiquitin-proteasome system as drug targets Nat. Rev. Drug Discov. 10 2011 29 46
4. J.E. Brownell, M.D. Sintchak, J.M. Gavin, H. Liao, F.J. Bruzzese, N.J. Bump, T.A. Soucy, M.A. Milhollen, X. Yang, and A.L. Burkhardt Substrate-assisted inhibition of ubiquitin-like protein-activating enzymes: the NEDD8 E1 inhibitor MLN4924 forms a NEDD8-AMP mimetic in situ Mol. Cell 37 2010 102 111
5. C.B. Carlson, R.A. Horton, and K.W. Vogel A toolbox approach to high-throughput TR-FRET-based SUMOylation and DeSUMOylation assays Assay Drug Dev. Technol. 7 2009 348 355
6. D.F. Ceccarelli, X. Tang, B. Pelletier, S. Orlicky, W. Xie, V. Plantevin, D. Neculai, Y.C. Chou, A. Ogunjimi, and A. Al-Hakim An allosteric inhibitor of the human Cdc34 ubiquitin-conjugating enzyme Cell 145 2011 1075 1087
7. T.L. Chung, H.H. Hsiao, Y.Y. Yeh, H.L. Shia, Y.L. Chen, P.H. Liang, A.H. Wang, K.H. Khoo, and S. Shoei-Lung Li In vitro modification of human centromere protein CENP-C fragments by small ubiquitin-like modifier (SUMO) protein: definitive identification of the modification sites by tandem mass spectrometry analysis of the isopeptides J. Biol. Chem. 279 2004 39653 39662
8. P. Cohen, and M. Tcherpakov Will the ubiquitin system furnish as many drug targets as protein kinases? Cell 143 2010 686 693
9. N. Cotelle, J.L. Bernier, J.P. Hénichart, J.P. Catteau, E. Gaydou, and J.C. Wallet Scavenger and antioxidant properties of ten synthetic flavones Free Radic. Biol. Med. 13 1992 211 219
10. N. Cotelle, J.L. Bernier, J.P. Catteau, J. Pommery, J.C. Wallet, and E.M. Gaydou Antioxidant properties of hydroxy-flavones Free Radic. Biol. Med. 20 1996 35 43
11. S.D. Desai, T.K. Li, A. Rodriguez-Bauman, E.H. Rubin, and L.F. Liu Ubiquitin/26S proteasome-mediated degradation of topoisomerase I as a resistance mechanism to camptothecin in tumor cells Cancer Res. 61 2001 5926 5932
12. J.M. Desterro, M.S. Rodriguez, and R.T. Hay SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation Mol. Cell 2 1998 233 239
13. J.J. Driscoll, D. Pelluru, K. Lefkimmiatis, M. Fulciniti, R.H. Prabhala, P.R. Greipp, B. Barlogie, Y.T. Tai, K.C. Anderson, and J.D. Shaughnessy Jr. The sumoylation pathway is dysregulated in multiple myeloma and is associated with adverse patient outcome Blood 115 2010 2827 2834
14. X. Duan, J.O. Trent, and H. Ye Targeting the SUMO E2 conjugating enzyme Ubc9 interaction for anti-cancer drug design Anticancer. Agents Med. Chem. 9 2009 51 54
15. C. Fanslau, D. Pedicord, S. Nagulapalli, H. Gray, S. Pang, L. Jayaraman, J. Lippy, and Y. Blat An electrophoretic mobility shift assay for the identification and kinetic analysis of acetyl transferase inhibitors Anal. Biochem. 402 2010 65 68
16. I. Fukuda, A. Ito, G. Hirai, S. Nishimura, H. Kawasaki, H. Saitoh, K. Kimura, M. Sodeoka, and M. Yoshida Ginkgolic acid inhibits protein SUMOylation by blocking formation of the E1-SUMO intermediate Chem. Biol. 16 2009 133 140
17. I. Fukuda, A. Ito, M. Uramoto, H. Saitoh, H. Kawasaki, H. Osada, and M. Yoshida Kerriamycin B inhibits protein SUMOylation J. Antibiot. 62 2009 221 224
18. J.R. Gareau, and C.D. Lima The SUMO pathway: emerging mechanisms that shape specificity, conjugation and recognition Nat. Rev. Mol. Cell Biol. 11 2010 861 871
19. M.C. Geoffroy, E.G. Jaffray, K.J. Walker, and R.T. Hay Arsenic-induced SUMO-dependent recruitment of RNF4 into PML nuclear bodies Mol. Biol. Cell 21 2010 4227 4239
20. F. Golebiowski, I. Matic, M.H. Tatham, C. Cole, Y. Yin, A. Nakamura, J. Cox, G.J. Barton, M. Mann, and R.T. Hay System-wide changes to SUMO modifications in response to heat shock Sci. Signal. 2 2009 ra24
21. J.D. Kessler, K.T. Kahle, T. Sun, K.L. Meerbrey, M.R. Schlabach, E.M. Schmitt, S.O. Skinner, Q. Xu, M.Z. Li, and Z.C. Hartman A SUMOylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis Science 335 2012 348 353
22. M. Laget, M. DeMeo, J.C. Wallet, E.M. Gaydou, H. Guiraud, and G. Dumenil Antimutagenic activities of 24 synthetic flavones with the Salmonella microsomal assay Arch. Pharm. Res. 18 1995 415 422
23. X. Lei, R.P. Johnson, and J.A. Porco Jr. Total synthesis of the ubiquitin-activating enzyme inhibitor (+)-panepophenanthrin Angew. Chem. Int. Ed. Engl. 42 2003 3913 3917
24. A. Majumdar, A.D. Petrescu, Y. Xiong, and N. Noy Nuclear translocation of cellular retinoic acid-binding protein II is regulated by retinoic acid-controlled SUMOylation J. Biol. Chem. 286 2011 42749 42757
25. Y. Mao, M. Sun, S.D. Desai, and L.F. Liu SUMO-1 conjugation to topoisomerase I: A possible repair response to topoisomerase-mediated DNA damage Proc. Natl. Acad. Sci. USA 97 2000 4046 4051
26. Y.Y. Mo, and S.J. Moschos Targeting Ubc9 for cancer therapy Expert Opin. Ther. Targets 9 2005 1203 1216
27. S. Müller, M.J. Matunis, and A. Dejean Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus EMBO J. 17 1998 61 70
28. S. Müller, C. Hoege, G. Pyrowolakis, and S. Jentsch SUMO, ubiquitin's mysterious cousin Nat. Rev. Mol. Cell Biol. 2 2001 202 210
29. A. Pichler, P. Knipscheer, E. Oberhofer, W.J. van Dijk, R. Körner, J.V. Olsen, S. Jentsch, F. Melchior, and T.K. Sixma SUMO modification of the ubiquitin-conjugating enzyme E2-25K Nat. Struct. Mol. Biol. 12 2005 264 269
30. P.R. Potts, and H.T. Yu Human MMS21/NSE2 is a SUMO ligase required for DNA repair Mol. Cell. Biol. 25 2005 7021 7032
31. I. Psakhye, and S. Jentsch Protein group modification and synergy in the SUMO pathway as exemplified in DNA repair Cell 151 2012 807 820
32. M.S. Rodriguez, C. Dargemont, and R.T. Hay SUMO-1 conjugation in vivo requires both a consensus modification motif and nuclear targeting J. Biol. Chem. 276 2001 12654 12659
33. N. Rouleau, J. Wang, L. Karras, E. Andrews, M. Bielefeld-Sevigny, and Y. Chen Highly sensitive assays for SUMOylation and small ubiquitin-like modifier-dependent protein-protein interactions Anal. Biochem. 375 2008 364 366
34. N. Saitoh, Y. Uchimura, T. Tachibana, S. Sugahara, H. Saitoh, and M. Nakao In situ SUMOylation analysis reveals a modulatory role of RanBP2 in the nuclear rim and PML bodies Exp. Cell Res. 312 2006 1418 1430
35. D. Schmidt, and S. Müller PIAS/SUMO: new partners in transcriptional regulation Cell. Mol. Life Sci. 60 2003 2561 2574
36. A. Seyoum, K. Asres, and F.K. El-Fiky Structure-radical scavenging activity relationships of flavonoids Phytochemistry 67 2006 2058 2070
37. T.A. Soucy, P.G. Smith, M.A. Milhollen, A.J. Berger, J.M. Gavin, S. Adhikari, J.E. Brownell, K.E. Burke, D.P. Cardin, and S. Critchley An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer Nature 458 2009 732 736
38. A. Tjernberg, D. Hallén, J. Schultz, S. James, K. Benkestock, S. Byström, and J. Weigelt Mechanism of action of pyridazine analogues on protein tyrosine phosphatase 1B (PTP1B) Bioorg. Med. Chem. Lett. 14 2004 891 895
39. S. Tsubuki, Y. Saito, M. Tomioka, H. Ito, and S. Kawashima Differential inhibition of calpain and proteasome activities by peptidyl aldehydes of di-leucine and tri-leucine J. Biochem. 119 1996 572 576
40. H.D. Ulrich The SUMO system: an overview Methods Mol. Biol. 497 2009 3 16
41. D. Ungermannova, S.J. Parker, C.G. Nasveschuk, D.A. Chapnick, A.J. Phillips, R.D. Kuchta, and X. Liu Identification and mechanistic studies of a novel ubiquitin E1 inhibitor J. Biomol. Screen. 17 2012 421 434
42. D. Ungermannova, S.J. Parker, C.G. Nasveschuk, W. Wang, B. Quade, G. Zhang, R.D. Kuchta, A.J. Phillips, and X. Liu Largazole and its derivatives selectively inhibit ubiquitin activating enzyme (e1) PLoS ONE 7 2012 e29208
43. T. Van Nguyen, P. Angkasekwinai, H. Dou, F.M. Lin, L.S. Lu, J. Cheng, Y.E. Chin, C. Dong, and E.T. Yeh SUMO-specific protease 1 is critical for early lymphoid development through regulation of STAT5 activation Mol. Cell 45 2012 210 221
44. A. Verger, J. Perdomo, and M. Crossley Modification with SUMO. A role in transcriptional regulation EMBO Rep. 4 2003 137 142
45. L. Wang, and S. Banerjee Differential PIAS3 expression in human malignancy Oncol. Rep. 11 2004 1319 1324
46. L.D. Wood, B.J. Irvin, G. Nucifora, K.S. Luce, and S.W. Hiebert Small ubiquitin-like modifier conjugation regulates nuclear export of TEL, a putative tumor suppressor Proc. Natl. Acad. Sci. USA 100 2003 3257 3262
47. Y. Xiang, G. Asmussen, M. Booker, B. Hirth, J.L. Kane Jr., J. Liao, K.D. Noson, and C. Yee Discovery of novel sphingosine kinase 1 inhibitors Bioorg. Med. Chem. Lett. 19 2009 6119 6121
48. Y. Xiang, B. Hirth, J.L. Kane Jr., J. Liao, K.D. Noson, C. Yee, G. Asmussen, M. Fitzgerald, C. Klaus, and M. Booker Discovery of novel sphingosine kinase-1 inhibitors. Part 2 Bioorg. Med. Chem. Lett. 20 2010 4550 4554
49. M. Yang, C.T. Hsu, C.Y. Ting, L.F. Liu, and J. Hwang Assembly of a polymeric chain of SUMO1 on human topoisomerase I in vitro J. Biol. Chem. 281 2006 8264 8274
50. Y. Yang, J. Kitagaki, R.M. Dai, Y.C. Tsai, K.L. Lorick, R.L. Ludwig, S.A. Pierre, J.P. Jensen, I.V. Davydov, and P. Oberoi Inhibitors of ubiquitin-activating enzyme (E1), a new class of potential cancer therapeutics Cancer Res. 67 2007 9472 9481
51. J. Zhao Sumoylation regulates diverse biological processes Cell. Mol. Life Sci. 64 2007 3017 3033
52. X.L. Zhao, and G. Blobel A SUMO ligase is part of a nuclear multiprotein complex that affects DNA repair and chromosomal organization Proc. Natl. Acad. Sci. USA 102 2005 4777 4782
53. H.J. Zhong, V.P. Ma, Z. Cheng, D.S. Chan, H.Z. He, K.H. Leung, D.L. Ma, and C.H. Leung Discovery of a natural product inhibitor targeting protein neddylation by structure-based virtual screening Biochimie 94 2012 2457 2460